Correvio Pharma Corp. Retained Earnings
Correvio Pharma Corp. had Retained Earnings of -$444.93 million as of 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2020-04-30
- 2019-12-31: Retained Earnings (Accumulated Deficit) -$444.93M.
- 2018-12-31: Retained Earnings (Accumulated Deficit) -$409.74M.
- 2018-01-01: Retained Earnings (Accumulated Deficit) -$393.17M.
- 2017-12-31: Retained Earnings (Accumulated Deficit) -$392.87M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2019-12-31 | -$444.93M 20-F · filed 2020-04-30 |
| 2018-12-31 | -$409.74M 20-F · filed 2020-04-30 |
| 2018-01-01 | -$393.17M 20-F · filed 2020-04-30 |
| 2017-12-31 | -$392.87M 20-F · filed 2020-04-30 |
| 2016-12-31 | -$363.05M 20-F · filed 2018-04-30 |
| 2015-12-31 | -$343.44M 40-F · filed 2017-03-29 |
| 2014-12-31 | -$318.97M 40-F · filed 2016-03-29 |
| 2013-12-31 | -$300.75M 40-F · filed 2015-03-27 |
| 2012-12-31 | -$305.52M 40-F/A · filed 2014-04-30 |
| 2011-12-31 | -$287.20M 20-F/A · filed 2013-04-18 |
| 2010-12-31 | -$259.28M 40-F/A · filed 2012-04-25 |